Evidence map›Paper›PMID 35687082›Full record

ArticleAnnals of neurology2022

Reply to: Cognitive Effects of Deep Brain Stimulation in GBA-Related Parkinson's Disease.

Gian Pal, Graziella Mangone, Bichun Ouyang, Debra Ehrlich, Rachel Saunders-Pullman, Susan Bressman, Roy N Alcalay, Karen Marder, Jan Aasly, M Maral Mouradian and 11 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Genetic testing for Parkinson's disease in clinical practice.Journal of neural transmission (Vienna, Austria : 1996) · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Gian PalDepartment of Neurology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ.ORCID 0000-0003-1048-6182
Graziella MangoneSorbonne Université, Assistance Publique Hôpitaux de Paris, Inserm, CNRS, Institut du Cerveau - Paris Brain Institute - ICM, Pitié-Salpêtrière Hospital, Department of Neurology, Centre d'Investigation Clinique Neurosciences, Paris, France.
Bichun OuyangDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL.
Debra EhrlichParkinson's Disease Clinic, Office of the Clinical Director, NIH/NINDS, Bethesda, MD.
Rachel Saunders-PullmanDepartment of Neurology, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai, NY, New York.
Susan BressmanDepartment of Neurology, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai, NY, New York.
Roy N AlcalayDepartment of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY.
Karen MarderDepartment of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY.
Jan AaslyDepartment of Neurology, St. Olavs Hospital and Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway.
M Maral MouradianDepartment of Neurology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ.
Sharlet AndersonDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL.
Bryan BernardDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL.
Glenn StebbinsDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL.
Sepehr SaniDepartment of Neurosurgery, Rush University Medical Center, Chicago, IL.
Mitra AfshariDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL.
Leo VerhagenDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL.
Rob M A de BieDepartment of Neurology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
Tom FoltynieDepartment of Clinical & Movement Neurosciences, UCL Institute of Neurology, London, UK.
Deborah HallDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL.ORCID 0000-0003-2772-7851
Jean-Christophe CorvolSorbonne Université, Assistance Publique Hôpitaux de Paris, Inserm, CNRS, Institut du Cerveau - Paris Brain Institute - ICM, Pitié-Salpêtrière Hospital, Department of Neurology, Centre d'Investigation Clinique Neurosciences, Paris, France.
Christopher G GoetzDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL.ORCID 0000-0003-1665-8205

Funding

Parkinson disease and DBS: cognitive effects in GBA mutation carriersK23NS097625 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI PAL, GIAN D · 2017 to 2021
$936k
NINDS NIH HHS K23 NS097625NINDS NIH HHS K23-NS097625-05NINDS NIH HHS L30 NS103289
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Deep Brain StimulationParkinson DiseaseCognitionGlucosylceramidaseHumansMutationGlucosylceramidase

Identifiers

PMID35687082
PMCPMC10540153

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.